• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].

作者信息

Oda Yoshiko, Washio Ken, Mizuno Mayuko, Imamura Shinya, Nishigori Chikako, Fukunaga Atsushi

机构信息

Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine.

出版信息

Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.

DOI:10.15036/arerugi.70.1196
PMID:34759084
Abstract
摘要

相似文献

1
[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].[慢性自发性荨麻疹患者外周嗜碱性粒细胞经奥马珠单抗治疗后有何变化？]
Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.
2
Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.对奥马珠单抗有反应的慢性自发性荨麻疹患者独特的嗜碱性粒细胞微小RNA特征。
Clin Exp Allergy. 2021 Dec;51(12):1648-1652. doi: 10.1111/cea.14014. Epub 2021 Sep 20.
3
A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria.循环嗜碱性粒细胞数量极低预示着慢性自发性荨麻疹患者对奥马珠单抗治疗反应不佳。
Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.
4
Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.改善的 FcεRI 介导的 CD203c 嗜碱性粒细胞反应反映了奥马珠单抗对慢性自发性荨麻疹的快速反应。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1166-1176.e8. doi: 10.1016/j.jaip.2020.08.048. Epub 2020 Sep 6.
5
Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria.嗜碱性粒细胞组胺释放试验阳性预示慢性自发性荨麻疹患者对标准剂量奥马珠单抗反应不足。
Clin Exp Allergy. 2023 Dec;53(12):1318-1321. doi: 10.1111/cea.14402. Epub 2023 Sep 28.
6
Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.奥马珠单抗对慢性特发性/自发性荨麻疹患者血液嗜碱性粒细胞计数的影响。
J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.
7
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.奥马珠单抗对慢性自发性荨麻疹合并多种慢性诱导性荨麻疹患者有效。
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
8
Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.奥马珠单抗对慢性荨麻疹患者嗜碱性粒细胞影响的双盲安慰剂对照试验。
Clin Exp Allergy. 2018 Feb;48(2):196-204. doi: 10.1111/cea.13066. Epub 2017 Dec 12.
9
Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.奥马珠单抗治疗慢性自发性荨麻疹患者外周血嗜碱性粒细胞的反应。
J Allergy Clin Immunol. 2021 Jun;147(6):2295-2304.e12. doi: 10.1016/j.jaci.2021.02.039. Epub 2021 Mar 12.
10
Basophil FcɛRI expression is linked to time to omalizumab response in chronic spontaneous urticaria.嗜碱性粒细胞FcɛRI表达与慢性自发性荨麻疹患者对奥马珠单抗产生反应的时间相关。
J Allergy Clin Immunol. 2018 Jun;141(6):2313-2316.e1. doi: 10.1016/j.jaci.2018.02.021. Epub 2018 Mar 5.